Literatur
Alschibaja M, May F, Treiber U et al. (2005) Transurethral resection for benign prostatic hyperplasia. current developments. Urologe A 44(5): 499–504
Argirovic D (2006) Transurethral incision of the prostate (TUIP): long-term results. Eur Urol Suppl 5(2): 273
Bachmann A, Ruszat R, Seifert H et al. (2005) Photoselektive Vaporisation der Prostata (PVP) vs. Transurethrale Elektroresektion der Prostata (TUR-P). Urologe 44 [Suppl 1]: 51
Bachmann A, Ruszat R, Wyler S et al. (2005) Photoselective vaporization of the prostate: the Basel experience after 108 procederes. Eur Urol 47: 786–804
Bachmann A, Schurch L, Ruszat R et al. (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-center study of perioperative morbidity and eerly functional outcome. Eur Urol 48: 965–972
Barba M, Hartung R, Fastenmeier K, Leyh H (1999) Koagulierendes intermittierendes Schneiden. Eine neue Technik für die transurethrale Hochfrequenzchirurgie. Min Invas Chir 1999: 108–112
Barry MJ, Cockett AT, Holtgrewe HL et al. (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150: 351–358
Berges RR, Pientka L, Höfner K et al. (2001) Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol 39: 682–687
Berges R, Dreikorn K, Hofner K et al. (2003) Leitlinien der Deutschen Urologen zur Diagnostik des Benignen Prostata Syndroms (BPS). Urologe A 42: 584–590
Bertolott F, Raggio M, Vigliercio G et al. (2006) Monopolar vs. bipolar TUR: results of a randomised prospective study Eur Urol 5 [Suppl 2]: 311
Bonkhoff K, Fornara P, Gleißner J et al. (2002): PSA-Bestimmung in der Prostatakarzinomdiagnostik (Früherkennung des Prostatakarzinoms), AWMF-Leitlinien-Register Nr. 043/036, AWMF
Bosch JLHR (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13: 17–20
Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoided residual urine determination in evaluation of prostatism. Urology 20: 602–604
Chandrasekera S, Barber Nj, Walsh K et al. (2005) Green Light PVP: Safety and efficacy in large prostates >100 cc. J Urol 173 [4 Suppl]: 1569
Debruyne FM, Jardin A, Colloi D et al. (1998) Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. Eur Urol 34: 169–175
De la Rosette, Alivizatos G, Madersbacher S et al. (2004) Guidelines on benign prostatic hyperplasia. European association of Urolog, Update 03/2004
De Sio M, Autorino R, Quarto G et al. (2006) Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology 67: 69–72
Donohue JF, Sharma H, Abraham R et al. (2002) Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finaste ride for decreasing operative blood loss. J Urol 168(5): 2024–2026
Dunsmuir WD, McFarlane JP, Tan A et al. (2003) Gyrus bipolar electrovaporization vs transurathral resection of the prostate: a randomized prospective single-blind trial with 1-year follow-up. Prostate Cancer Prostatic Dis 6: 182–186
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP) the endourologic alternative to open prostatectomie Eur Urol 49: 87–91
Faul P (1993) Video TUR: raising the gold standard. New aspects, techniques and tendencies to minimize invasiveness. Eur Urol 24(2): 256–261
Flachenecker G, Fastenmeier K (1976) Die TUR-P mit Hochfrequenzströmen aus elektrotechnischer Sicht. Urologe A 15: 167
Flachenecker G, Fastenmeier K (1979) High frequency current effects during TUR-P. J Urol 122: 336
Freyer P (1900) A new method of performing prostatectomy. Lancet 1: 774
Gilling P, Neill M, Kennett K et al. (2005) Relief of bladder outflow obstruction following HoLEP and TUR-P: A pooled analysis of data from 4 randomized trails. J Urol 173 [Suppl 4]: 1390
Hald T (1989) Urodynamics in benign prostatic hyperplasia. Prostate 2 [Suppl]: 69–77
Hampson SJ, Noble JG, Richards D, Milroy EJG (1992) Does residual urine predispose to urinary tract infection? Br J Urol 70: 506–508
Hartung R (1979) Die hydraulische Stimulierung des M. sphincter externus. Urologe A 18: 203
Hartung R, Mauermayer W, Beck F, Karcher G (1976) Die kontrollierte TUR: Eine neue Messmethode zur Bestimmung des intraoperativen Blutverlustes bei der TUR. Urologe A 15: 254–257
Hartung R, Egger B, Mauermayer W (1980) How to teach the TUR 75. Annual Meeting of the American Urological Association
Hartung R, Leyh H, Liapi C et al. (2001) Coagulating intermittent cutting. Improved high-frequency surgery in transurethral prostatetectomy. Eur Urol 39: 676–681
Hartung R, May F (2002) Transurethral resection of the prostate. Aktuelle Urol 33: 469–482
Herrmann TRW, Bach T, Cellarius C et al. (2006) Bladder Neck Incision in Oupatient Setting. A Feasable Procedure Using Revolix 2 Micron CW-Laser. J Endourol 112
Herrmann TRW, Gross AJ, Schultheiss D et al. (2006) Transurethral microwave therapy for the treatment of BPH: still a challenger? World J Urol (accepted for publication)
Hill B, Belville W, Bruskewitz R et al. (2004) Transurethral needle ablation versus transurethral resection of the prostate for treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171: 2336–2340
Höfner K (2000) Urodynamik. In: Höfner K, Stief CG, Jonas U (eds) Benigne Prostatahyperplasie. Ein Leitfaden für die Praxis. BSpringer, Berlin Heidelberg New York, S 200–222
Holmes M, Cox J, Stewart J et al. (2002) Thick vs thin loop transurethral resection of the prostate: a double-blind prospective trial of early morbidity. BJU Int 89: 197–201
Jimenez-Cruz F (2003) Identifying the patients at risk for disease progression. Eur Urol 2 [Suppl]: 6–12
Kirby R, Roehrborn CG, Boyle P et al. (2003) Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology 61: 119–126
Kuntz R, Ahyai S, Fayad A, Howorka A (2005) Transurethrale Holmium-Laser-Enukleation der Prostata (HoLEP) – perioperative Ergebnisse von 1100 konsekutiven Patienten. Urologe 44 [Suppl 1]: 51
Lepor H, Williford WO, Barry MJ et al. (1996) The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med 335: 533–539
Konert J, Dietrich HG (2004) Illustrierte Geschichte der Urologie. Springer, Berlin Heidelberg New York
Koshiba K, Egawa S, Ohori M et al. (1995) Does transurethral resection of the prostate pose a risk to life? 22-years outcome. J Urol 153: 1506–1509
Madersbacher S, Lackner J, Brossner C et al. (2005) Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47(4): 499–504
Mauermayer W (1962) Indikationsstellung/Technik/Nachbehandlung: Die transurethralen Operationen. Lehmanns, München
Mauermayer W (1981) Allgemeine und spezielle Operationslehre: Transurethrale Operationen. Springer, Berlin Heidelberg New York
McConnell JD, Bruskewitz R, Walsh P et al. (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 338: 557–563
McConnell JD, Roehrborn CG, Bautista O et al. (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349: 2387–2398
Michel MS, Knoll T, Trojan L et al. (2003) Rotoresect for bloodless transurethral resection of the prostate: a 4-year follow-up. BJU Int 91(1): 65–68
Millin R (1945) Retropubic prostatectomy: New extravesical technique: report on 20 cases. Lancet 246(6379): 693–696
Oelke M, Höfner K, Wiese B et al. (2002) Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World J Urol 19: 443–452
Reuter MA, Reuter HJ (1998) Geschichte der Endoskopie. Krämer, Stuttgart
Reynard JM, Yang Q, Donovan JL et al. (1998) The ICS-’BPH‘ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 82: 619–623
Rosier PF, de la Rosette JJ (1995) Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 13: 9–13
Schatzl G, Madersbacher S, Djavan B et al. (2000) Two-year results of transurethral resection of the prostate versus four ‚less invasive‘ treatment options. Eur Urol 37(6): 695–701
Schultheiss D, Rathert P, Jonas U (1999) Streiflichter aus der Geschichte der Urologie. Springer, Berlin Heidelberg New York
Schultheiss D, Rathert P, Jonas U (2002) Wegbereiter der Urologie. Springer, Berlin Heidelberg New York
Staehler W (1940) Anzeigestellung und Technik der intravesikalen Operationsverfahren. Operative Cystoskopie. Thieme, Leipzig
Starkman JS, Santucci RA (2005) Comparsion of bipolar transurethral resection of the prostate with standard transurethral prostataectomy: shoter stay, earlier catheter removal and fewer complications. BJU Int 95: 69–71
Talic RF, El Tiraifi A, El Faqih SR et al. (2002) Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology 55: 886–890
Tefekli A, Muslumanoglu AY, Baykal M et al. (2005) A hybrid technique using bipolar energy in transurethral prostate surgery: a prospective, randomized comparsion. J Urol 174: 1339–1343
Terrone C, Scoffone C, Cracco C et al. (2006) Bipolar vs. monopolar TUR-P: A randomized study. Eur Urol 5 [Suppl 2]: 235
Van Venrooij GE, Boon TA, de Gier RP (1995) International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 153: 1516–1519
Varkarakis J, Bartsch G et al. (2004) Long-term morbidity and mortality. Prostate 58: 248–251
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jonas, U., Gabouev, A.I., Herrmann, T.R.W. et al. Benigne Prostatahyperplasie. Urologe 45 (Suppl 4), 134–144 (2006). https://doi.org/10.1007/s00120-006-1139-y
Issue Date:
DOI: https://doi.org/10.1007/s00120-006-1139-y